SeaStar Medical Holding Corp. Announces Board and Executive Changes
Ticker: ICUCW · Form: 8-K · Filed: Sep 29, 2025 · CIK: 1831868
| Field | Detail |
|---|---|
| Company | Seastar Medical Holding CORP (ICUCW) |
| Form Type | 8-K |
| Filed Date | Sep 29, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001, $11.50, $50,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-of-directors, executive-compensation
TL;DR
SeaStar Medical Holding Corp. is shuffling its board and execs, effective Sept 23, 2025.
AI Summary
SeaStar Medical Holding Corp. announced on September 23, 2025, changes in its board of directors and executive compensation arrangements. The filing details the departure of certain officers and directors, the election of new directors, and updates to compensatory arrangements for key personnel. These changes are effective as of September 23, 2025.
Why It Matters
Changes in a company's leadership and compensation structures can signal shifts in strategy or operational focus, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in board and executive leadership can introduce uncertainty about future strategy and operational stability.
Key Players & Entities
- SeaStar Medical Holding Corp. (company) — Registrant
- September 23, 2025 (date) — Effective date of changes
FAQ
What specific roles have been affected by the departure of officers or directors?
The filing indicates departures of certain officers and directors but does not specify the exact roles in this summary.
Who are the newly elected directors?
The filing mentions the election of directors but does not name them in this summary.
What are the key changes in compensatory arrangements?
The filing notes updates to compensatory arrangements for certain officers but does not detail these changes in this summary.
What is the effective date of these reported changes?
The effective date for all reported changes, including departures, elections, and compensatory arrangements, is September 23, 2025.
What is the primary reason for these board and executive changes?
The filing does not explicitly state the reasons for these changes, only that they are occurring.
Filing Stats: 558 words · 2 min read · ~2 pages · Grade level 15 · Accepted 2025-09-29 16:28:05
Key Financial Figures
- $0.0001 — ich registered Common Stock par value $0.0001 per share ICU The Nasdaq Stock Marke
- $11.50 — sable for one share of Common Stock for $11.50 per share ICUCW The Nasdaq Stock Ma
- $50,000 — g expenses to increase by approximately $50,000. SIGNATURES Pursuant to the requirem
Filing Documents
- icu20250928_8k.htm (8-K) — 26KB
- 0001437749-25-030023.txt ( ) — 174KB
- icu-20250923.xsd (EX-101.SCH) — 4KB
- icu-20250923_def.xml (EX-101.DEF) — 14KB
- icu-20250923_lab.xml (EX-101.LAB) — 18KB
- icu-20250923_pre.xml (EX-101.PRE) — 14KB
- icu20250928_8k_htm.xml (XML) — 5KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SeaStar Medical Holding Corporation By: /s/ Eric Schlorff Date: September 29, 2025 Name: Eric Schlorff Title: Chief Executive Officer